Steve Bucciarelli – HD Insights

Steve Bucciarelli

This is my bio

Loss of our friend, Dr. Kimberly Quaid de Cordon

Posted by Steve Bucciarelli - July 27, 2017

We heard today that Kimberly Quaid de Cordon, PhD, died in a tragic accident, and we now are mourning the loss of our friend and long time HSG colleague. Kim was…

Read More

Letter from the Deputy Editor

Posted by Steve Bucciarelli - September 28, 2017

Read More

Welcome new staff member, members of leadership team

Posted by Steve Bucciarelli - July 21, 2017

The Huntington Study Group is pleased to announce a new staff member and new members of the leadership team. Anne Van Dusen, CHC, is HSG’s new Director of Education &…

Read More

Overnight Switch from Tetrabenazine to Deutetrabenazine Safe, Trial Shows

Posted by Steve Bucciarelli - July 11, 2017

JAMA Neurology paper published today from ARC-HD Trial People with Huntington disease-associated chorea can safely convert overnight from tetrabenazine to deutetrabenazine (brand name: Austedo), according to the results of the…

Read More

HD Insights Volume 17 (PDF)

Posted by Steve Bucciarelli - May 30, 2017

[pdf-embedder url=”https://huntingtonstudygroup.org/wp-content/uploads/2017/05/HD-Insights-Vol.-17-v.12-FINAL.pdf”] For a non-PDF version of HD Insights Vol. 17, click here.

Read More

FDA approves deutetrabenazine (AUSTEDO™) to treat chorea

Posted by Steve Bucciarelli - May 30, 2017

On April 3, 2017, the FDA approved a new drug, deutetrabenazine, to treat HD-associated chorea. By: Sara LaJeunesse, MSc Deutetrabenazine (AUSTEDO™, see HD Insights, Vol. 7) is the first deuterated…

Read More

Meet the Scientist : Beverly Davidson

Posted by Steve Bucciarelli - May 30, 2017

VITAL SIGNS NAME: Beverly Davidson, PhD TITLE: Chief Scientific Strategy Officer at the Children’s Hospital of Philadelphia (CHOP); Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics;…

Read More

Game-changing gene-silencing therapies for HD

Posted by Steve Bucciarelli - May 30, 2017

VITAL SIGNS NAME: Amber Southwell, PhD TITLE: Assistant Professor of Neuroscience, Burnett School of Biomedical Sciences, University of Central Florida EDUCATION: PhD, California Institute of Technology; post-doctoral research fellowship, University…

Read More

Research Round-Up

Posted by Steve Bucciarelli - May 30, 2017

By: Lise Munsie, PhD In neurons… The HD Induced Pluripotent Stem Cell (iPSC) consortium differentiated HD patient iPSCs into neuronal cultures.1 RNA-seq and ChIP-seq analysis from these cultures indicated subtle…

Read More

Highlights of CHDI

Posted by Steve Bucciarelli - May 30, 2017

The 12th Annual CHDI HD Therapeutics Conference was held in St. Julian’s, Malta, April 24–27, 2017. By: Nicholas Caron, PhD The 12th Annual CHDI HD Therapeutics Conference in the town…

Read More